Found 31 results

2010
INTERACT Investigators, (Writing Committee), Anderson CS, Huang Y, Arima H, Heeley E, Skulina C, Parsons MW, Peng B, Li Q et al..  2010.  Effects of early intensive blood pressure lowering treatment on the growth of hematoma and perihematoma edema in acute intracerebral hemorrhage : the INTERACT trial. Stroke. 41:307-12.[IF6.499].
PROGRESS Collaborative Group, Writing Committee, Arima H, Tzourio C, Anderson C, Woodward M, Bousser MB, Macmahon S, Neal B, Chalmers J.  2010.  Effects of perindopril-based blood pressure lowering on probable cerebral amyloid angiopathy-related intracerebral hemorrhage: the PROGRESS trial. Stroke. 41 :394-6.[IF6.499].
Czernichow S , Lee CMY, Barzi F , Greenfield J, Baur LA, Chalmers J, Woodward M, Huxley RR.  2010.  Efficacy of weight-loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomised controlled trials. . Obesity Reviews . 11:150-8.[IF7.821].
ADVANCE Collaborative Group, Writing Committee, Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S et al..  2010.  The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax. Diabetologia. Epub. [IF 6.418]
PROGRESS Collaborative Group, Writing Committee, Arima H, Anderson C, Omae T, Liu L, Tzourio C, Woodward M, Macmahon S, Neal B et al..  2010.  Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial. Journal of Hypertension. 28 :395-400.[IF5.132].
2009
Dufouil C, Godin O, Chalmers J, Coskun O, Macmahon S, Tzourio-Mazoyer N, Bousser MG, Anderson C, Mazoyer B, Tzourio C.  2009.  Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke . 40:2219-21.[IF6.296]..
Patel A, Chalmers J, Macmahon S, Neal B.  2009.  ADVANCE Blood pressure lowering in diabetes - Letter to the Editor. J Clin Hypertens (Greenwich). 11:108.[IF0].
ADVANCE Collaborative Group, Writing Committee, Ninomiya T, Perkovic V, de Galan B, Zoungas S, Pillai A, Jardine M, Patel A, Cass A et al..  2009.  Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 20:1813-21.[IF7.111]..
Zoungas S, Chalmers J, Patel A.  2009.  Cardiovascular risk in Type 2 diabetes . reflecting on the ADVANCE study. US Endocrinology. 5:95-9.[IF0.000].
Zoungas S, Chalmers J, Patel A.  2009.  Cardiovascular risk in Type 2 diabetes . reflecting on the ADVANCE study. Review. European Endocrinology. 5:42-46.[IF0.000].
Turnbull F, Arima H, Heeley E, Peiris D, Weekes A, Morgan C, Cass A, Anderson C, Patel A, Chalmers J.  2009.  Cardiovascular risk management among female and male patients in Australian General Practice: the AusHEART study. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. <i>Heart, Lung and Circulation</i>. 2009;8(Suppl 3):S272
Heeley E, Peiris D, Patel A, Cass A, Weekes A, Morgan C, Anderson C, Chalmers J.  2009.  Cardiovascular risk perception and the evidence practice gap in Australian General Practice (the AusHEART study). Medical Journal of Australia. In press. [IF 3.320]
Perkovic V, Ninomiya T, Macmahon S, Chalmers J.  2009.  Chapter 9: Renal and microalbuminuria data from ADVANCE. Role of Macro and Microcirculation in Target Organ Damage in Diabetes and Hypertension.
ADVANCE Collaborative Group, de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M et al..  2009.  Cognitive function and risks of cardiovascular disease and hypoglycaemia in people with type 2 diabetes; the ADVANCE trial. Diabetelogia. 52:2329-36.[IF6.418].
ADVANCE Collaborative Group, Writing Committee, Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, Macmahon S, Marre M et al..  2009.  The combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes; new results from ADVANCE. Diabetes Care. 32:2068-74.[IF7.349].
Brugts JJ, Ninomiya T, Boersma E, Remme W, Bertrand M, Ferrari R, Fox K, Macmahon S, Chalmers J, Simoons ML.  2009.  The consistency of the treatment effect of an ACE-inhibitor-based treatment regimen in patients with vascular disease or high-risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA and PROGRESS-trials comparing perindopril-ind. European Heart Journal. . 30:1385-94.[IF7.9].
Heeley E, Peiris D, Weekes A, Morgan C, Cass A, Anderson C, Patel A, Chalmers J.  2009.  Current prescribing of Blood Pressure lowering and statin therapies in Australian general practice according to risk level using new guidelines for cardiovascular risk assessment. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. <i>Heart, Lung and Circulation</i>. 2009;18(Suppl 3):S280
Travakoli M, Pumford N, Woodward M, Doney A, Chalmers J, Macmahon S, MacWalter R.  2009.  An economic evaluation of a Perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event. Eur J Health Econ . 10:111-9.[IF0.000]..
PROGRESS Collaborative Group, [Writing Committee], Ninomiya T, Donnan G, Anderson N, Bladin C, Chambers B, Gordon G, Sharpe N, Chalmers J et al..  2009.  Effects of the end point adjudication process on the results of the perindopril protection against recurrent stroke study (PROGRESS). Stroke . 40 :2111-5.[IF6.2]..
Chalmers J, Arima H.  2009.  Management of hypertension: evidence from the Blood Pressure Lowering Treatment Trialists. Collaboration and from major clinical trials. Polish Archives of Internal Medicine. 119:373-380.[IF0]..
Heeley E, Peiris D, Weekes A, Cass A, Anderson C, Patel A, Chalmers J.  2009.  Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction. 6th Asia Pacific Conference Against Stroke.
Heeley E, Peiris D, Weekes A, Cass A, Anderson C, Patel A, Chalmers J.  2009.  Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction. Proceedings of the 57th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. <i>Heart, Lung and Circulation</i>. 2009;18(Suppl 3):S280
Ninomiya T, Perkovic V, Verdon C, Barzi F , Cass A, Gallagher M, Jardine M, Anderson C, Chalmers J, Craig JC et al..  2009.  Proteinuria and stroke: a meta-analysis of cohort studies. American Journal of Kidney Diseases. 5:417-25.[IF3.981]..
ADVANCE Collaborative Group, Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S et al..  2009.  Risk of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and artrial fibrillation . results of the ADVANCE study. Eur Heart J. 30 :1128-35.[IF7.924]..
Joshi R , de Galan BE, Chalmers J, Perkovic V, Patel A.  2009.  Routine blood pressure lowering and intensive glucose control in patients with type 2 diabetes: results from the ADVANCE trial. Expert Reviews in Endocrinology & Metabolism. 4:111-18.[IF0].

Latest news

Recently added pages

Our focus

George Institute sites